Subject: Diseases of the digestive system. Gastroenterology | RC799-869 | Case Report | Article Subject
mesheuropmc: digestive system diseases
Sorafenib is an oral angiogenetic multikinase inhibitor approved in the treatment of renal and hepatocellular carcinoma. Bleeding and venous thrombotic events have been described with angiogenetic agents but cerebrovascular accidents are rarely reported. We report two c... View more
Ozenne, V, Paradis, V, Pernot, S. Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib.
European Journal of Gastroenterology and Hepatolog
. 2010; 147 (1): e1-e12